C1エステラーゼ阻害剤の世界市場インサイト・予測(~2025年)

【英語タイトル】Global C1 Esterase Inhibitor Market Insights, Forecast to 2025

QYResearchが出版した調査資料(QYR20FB04778)・商品コード:QYR20FB04778
・発行会社(調査会社):QYResearch
・発行日:2019年12月(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界のC1エステラーゼ阻害剤市場について調査・分析し、以下の構成でお届け致します。C1エステラーゼ阻害剤の種類別には、ヒト、組換えに、用途別には、病院、薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別C1エステラーゼ阻害剤売上データ
・地域別C1エステラーゼ阻害剤市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別C1エステラーゼ阻害剤市場規模:ヒト、組換え
・用途別C1エステラーゼ阻害剤市場規模:病院、薬局
・主要メーカーの企業情報:CSL Behring、Lev Pharmaceuticals、Salix Pharmaceuticals
・C1エステラーゼ阻害剤の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...
【レポートの概要】

The global C1 Esterase Inhibitor market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the C1 Esterase Inhibitor market based on company, product type, end user and key regions.
This report studies the global market size of C1 Esterase Inhibitor in key regions like North America, Europe, China and Japan, focuses on the consumption of C1 Esterase Inhibitor in these regions.
This research report categorizes the global C1 Esterase Inhibitor market by top players/brands, region, type and end user. This report also studies the global C1 Esterase Inhibitor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CSL Behring
Lev Pharmaceuticals
Salix Pharmaceuticals

C1 Esterase Inhibitor market size by Type
Human
Recombinant

C1 Esterase Inhibitor market size by Applications
Hospital
Pharmacy

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global C1 Esterase Inhibitor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of C1 Esterase Inhibitor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global C1 Esterase Inhibitor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of C1 Esterase Inhibitor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of C1 Esterase Inhibitor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of C1 Esterase Inhibitor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 C1 Esterase Inhibitor Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Type
1.4.2 Human
1.4.3 Recombinant
1.5 Market by Application
1.5.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global C1 Esterase Inhibitor Market Size
2.1.1 Global C1 Esterase Inhibitor Revenue 2014-2025
2.1.2 Global C1 Esterase Inhibitor Sales 2014-2025
2.2 C1 Esterase Inhibitor Growth Rate by Regions
2.2.1 Global C1 Esterase Inhibitor Sales by Regions
2.2.2 Global C1 Esterase Inhibitor Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 C1 Esterase Inhibitor Sales by Manufacturers
3.1.1 C1 Esterase Inhibitor Sales by Manufacturers
3.1.2 C1 Esterase Inhibitor Sales Market Share by Manufacturers
3.2 C1 Esterase Inhibitor Revenue by Manufacturers
3.2.1 C1 Esterase Inhibitor Revenue by Manufacturers (2014-2019)
3.2.2 C1 Esterase Inhibitor Revenue Share by Manufacturers (2014-2019)
3.3 C1 Esterase Inhibitor Price by Manufacturers
3.4 C1 Esterase Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 C1 Esterase Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers C1 Esterase Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into C1 Esterase Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global C1 Esterase Inhibitor Sales by Type
4.2 Global C1 Esterase Inhibitor Revenue by Type
4.3 C1 Esterase Inhibitor Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global C1 Esterase Inhibitor Breakdown Data by Application

6 North America
6.1 North America C1 Esterase Inhibitor by Country
6.1.1 North America C1 Esterase Inhibitor Sales by Country
6.1.2 North America C1 Esterase Inhibitor Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America C1 Esterase Inhibitor by Type
6.3 North America C1 Esterase Inhibitor by Application

7 Europe
7.1 Europe C1 Esterase Inhibitor by Country
7.1.1 Europe C1 Esterase Inhibitor Sales by Country
7.1.2 Europe C1 Esterase Inhibitor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe C1 Esterase Inhibitor by Type
7.3 Europe C1 Esterase Inhibitor by Application

8 Asia Pacific
8.1 Asia Pacific C1 Esterase Inhibitor by Region
8.1.1 Asia Pacific C1 Esterase Inhibitor Sales by Region
8.1.2 Asia Pacific C1 Esterase Inhibitor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific C1 Esterase Inhibitor by Type
8.3 Asia Pacific C1 Esterase Inhibitor by Application

9 Central & South America
9.1 Central & South America C1 Esterase Inhibitor by Country
9.1.1 Central & South America C1 Esterase Inhibitor Sales by Country
9.1.2 Central & South America C1 Esterase Inhibitor Revenue by Country
9.1.3 Brazil
9.2 Central & South America C1 Esterase Inhibitor by Type
9.3 Central & South America C1 Esterase Inhibitor by Application

10 Middle East and Africa
10.1 Middle East and Africa C1 Esterase Inhibitor by Country
10.1.1 Middle East and Africa C1 Esterase Inhibitor Sales by Country
10.1.2 Middle East and Africa C1 Esterase Inhibitor Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa C1 Esterase Inhibitor by Type
10.3 Middle East and Africa C1 Esterase Inhibitor by Application

11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 Company Business Overview
11.1.3 CSL Behring C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.1.4 CSL Behring C1 Esterase Inhibitor Products Offered
11.1.5 CSL Behring Recent Development
11.2 Lev Pharmaceuticals
11.2.1 Lev Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Lev Pharmaceuticals C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Lev Pharmaceuticals C1 Esterase Inhibitor Products Offered
11.2.5 Lev Pharmaceuticals Recent Development
11.3 Salix Pharmaceuticals
11.3.1 Salix Pharmaceuticals Company Details
11.3.2 Company Business Overview
11.3.3 Salix Pharmaceuticals C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Salix Pharmaceuticals C1 Esterase Inhibitor Products Offered
11.3.5 Salix Pharmaceuticals Recent Development

12 Future Forecast
12.1 C1 Esterase Inhibitor Market Forecast by Regions
12.1.1 Global C1 Esterase Inhibitor Sales Forecast by Regions 2019-2025
12.1.2 Global C1 Esterase Inhibitor Revenue Forecast by Regions 2019-2025
12.2 C1 Esterase Inhibitor Market Forecast by Type
12.2.1 Global C1 Esterase Inhibitor Sales Forecast by Type 2019-2025
12.2.2 Global C1 Esterase Inhibitor Revenue Forecast by Type 2019-2025
12.3 C1 Esterase Inhibitor Market Forecast by Application
12.4 North America C1 Esterase Inhibitor Forecast
12.5 Europe C1 Esterase Inhibitor Forecast
12.6 Asia Pacific C1 Esterase Inhibitor Forecast
12.7 Central & South America C1 Esterase Inhibitor Forecast
12.8 Middle East and Africa C1 Esterase Inhibitor Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 C1 Esterase Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



【掲載企業】

CSL Behring、Lev Pharmaceuticals、Salix Pharmaceuticals

★調査レポート[C1エステラーゼ阻害剤の世界市場インサイト・予測(~2025年)] (コード:QYR20FB04778)販売に関する免責事項を必ずご確認ください。
★調査レポート[C1エステラーゼ阻害剤の世界市場インサイト・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆